Improving Medication Adherence in adolescents who had a Liver Transplant: iMALT

改善接受肝移植的青少年的药物依从性:iMALT

基本信息

  • 批准号:
    10255996
  • 负责人:
  • 金额:
    $ 100.05万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2018
  • 资助国家:
    美国
  • 起止时间:
    2018-09-20 至 2023-08-31
  • 项目状态:
    已结题

项目摘要

This submission brings together leading pediatric transplant centers, using the NIDDK's collaborative multisite trial (U01) grant mechanism, to investigate an innovative strategy to improve transplant outcomes by improving adherence to medication regimens. Nonadherence to immunosuppressant medications is the leading cause of organ rejection in adolescent transplant recipients. We will investigate a tailored telemetric intervention reduce the number of patients who have a rejection by improving adherence to medications in adolescents who had a liver transplant. This study will use the Medication Level Variability Index (MLVI) to inform the intervention. The MLVI is an innovative biomarker of adherence which calculates the degree of variability between immunosuppressant medication blood levels over time (higher variability = worse adherence). It is a robust predictor of organ rejection (MLVI>2 denotes clinically significant nonadherence, leading to higher rejection risk). At-risk adolescent liver transplant recipients (MLVI>2) will be enrolled in a randomized controlled trial across several transplant centers. In the active telemetric intervention arm (administered via telephone, FaceTime ® or Skype ® interfaces), experienced interventionists will remotely communicate with patients using a standardized but flexible intervention strategy. The intervention includes addressing psychological avoidance associated with self-care, and further includes reminders and problem- solving of identified barriers to adherence. Control arm participants will continue to receive standard-of-care at the site. The study will exclusively enroll at-risk patients, will continually monitor their progress through the MLVI marker, and will tailor the intervention to the adherence monitoring findings throughout the 2 year trial period. This study will thus investigate an innovative “personalized medicine” approach to target a remote intervention effort.
本次提交汇集了领先的儿科移植中心,使用NIDDK的 协作多中心试验(U 01)资助机制,研究创新战略, 通过提高对药物治疗方案的依从性来改善移植结果。治疗依从性差 免疫抑制药物是青少年器官移植排斥反应的主要原因 受惠人士我们将研究一种量身定制的遥测干预措施, 通过提高对肝脏移植青少年的药物依从性来减少排斥反应, 移植本研究将使用药物水平变异性指数(MLVI)来告知 干预MLVI是一种创新的依从性生物标志物,可计算 随着时间的推移,免疫抑制剂药物血液水平之间的变异性(较高的变异性= 更糟糕的是)。它是器官排斥反应的可靠预测因子(MLVI>2表示具有临床意义 不依从,导致更高的拒绝风险)。高危青少年肝移植受者 (MLVI>2)将被招募到几个移植中心的随机对照试验中。在 主动遥测干预臂(通过电话、FaceTime ®或Skype ®进行管理 接口),经验丰富的介入医生将使用 标准化但灵活的干预策略。干预措施包括解决 与自我护理相关的心理回避,还包括提醒和问题- 解决已确定的遵守障碍。对照组参与者将继续接受 在现场的护理标准。本研究将专门招募高危患者, 通过MLVI标记监测他们的进展,并根据依从性调整干预措施 在整个2年的试验期间监测结果。因此,本研究将调查 创新的“个性化医疗”方法,以远程干预为目标。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

EYAL SHEMESH其他文献

EYAL SHEMESH的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('EYAL SHEMESH', 18)}}的其他基金

Improving Medication Adherence in adolescents who had a Liver Transplant: iMALT
改善接受肝移植的青少年的药物依从性:iMALT
  • 批准号:
    9788434
  • 财政年份:
    2018
  • 资助金额:
    $ 100.05万
  • 项目类别:
Improving Medication Adherence in adolescents who had a Liver Transplant: iMALT
改善接受肝移植的青少年的药物依从性:iMALT
  • 批准号:
    10891339
  • 财政年份:
    2018
  • 资助金额:
    $ 100.05万
  • 项目类别:
Improving Medication Adherence in adolescents who had a Liver Transplant: iMALT
改善接受肝移植的青少年的药物依从性:iMALT
  • 批准号:
    10021643
  • 财政年份:
    2018
  • 资助金额:
    $ 100.05万
  • 项目类别:
Improving Medication Adherence in adolescents who had a Liver Transplant: iMALT
改善接受肝移植的青少年的药物依从性:iMALT
  • 批准号:
    10466911
  • 财政年份:
    2018
  • 资助金额:
    $ 100.05万
  • 项目类别:
Improving Medication Adherence in adolescents who had a Liver Transplant: iMALT
改善接受肝移植的青少年的药物依从性:iMALT
  • 批准号:
    10018172
  • 财政年份:
    2018
  • 资助金额:
    $ 100.05万
  • 项目类别:
Improving Medication Adherence in children who had a Liver Transplant: iMALT
提高肝移植儿童的药物依从性:iMALT
  • 批准号:
    9263382
  • 财政年份:
    2016
  • 资助金额:
    $ 100.05万
  • 项目类别:
Improving Medication Adherence in children who had a Liver Transplant: iMALT
提高肝移植儿童的药物依从性:iMALT
  • 批准号:
    9352316
  • 财政年份:
    2016
  • 资助金额:
    $ 100.05万
  • 项目类别:
Medication Adherence in Children Who Had a Liver Transplant (MALT)
接受肝移植 (MALT) 的儿童的药物依从性
  • 批准号:
    8023936
  • 财政年份:
    2009
  • 资助金额:
    $ 100.05万
  • 项目类别:
Medication Adherence in Children Who Had a Liver Transplant (MALT)
接受肝移植 (MALT) 的儿童的药物依从性
  • 批准号:
    8702150
  • 财政年份:
    2009
  • 资助金额:
    $ 100.05万
  • 项目类别:
Medication Adherence in Children Who Had a Liver Transplant (MALT)
接受肝移植 (MALT) 的儿童的药物依从性
  • 批准号:
    8293366
  • 财政年份:
    2009
  • 资助金额:
    $ 100.05万
  • 项目类别:

相似海外基金

Pharmacy-led Transitions of Care Intervention to Address System-Level Barriers and Improve Medication Adherence in Socioeconomically Disadvantaged Populations
药房主导的护理干预转型,以解决系统层面的障碍并提高社会经济弱势群体的药物依从性
  • 批准号:
    10594350
  • 财政年份:
    2023
  • 资助金额:
    $ 100.05万
  • 项目类别:
Evaluating Centralizing Interventions to Address Low Adherence to Lung Cancer Screening Follow-up in Decentralized Settings
评估集中干预措施,以解决分散环境中肺癌筛查随访依从性低的问题
  • 批准号:
    10738120
  • 财政年份:
    2023
  • 资助金额:
    $ 100.05万
  • 项目类别:
Suubi-Mhealth: A mobile health intervention to address depression and improve ART adherence among Youth living with HIV (YLHIV) in Uganda
Suubi-Mhealth:一种移动健康干预措施,旨在解决乌干达艾滋病毒感染者 (YLHIV) 青少年的抑郁症问题并提高抗逆转录病毒疗法的依从性
  • 批准号:
    10526768
  • 财政年份:
    2022
  • 资助金额:
    $ 100.05万
  • 项目类别:
Suubi-Mhealth: A mobile health intervention to address depression and improve ART adherence among Youth living with HIV (YLHIV) in Uganda
Suubi-Mhealth:一种移动健康干预措施,旨在解决乌干达艾滋病毒感染者 (YLHIV) 青少年的抑郁症问题并提高抗逆转录病毒疗法的依从性
  • 批准号:
    10701072
  • 财政年份:
    2022
  • 资助金额:
    $ 100.05万
  • 项目类别:
A behavioral intervention for Black men who have sex with men and live with HIV to address intersectional stigma and improve antiretroviral therapy adherence
针对男男性行为且感染艾滋病毒的黑人男性进行行为干预,以解决交叉耻辱并提高抗逆转录病毒治疗的依从性
  • 批准号:
    10679092
  • 财政年份:
    2021
  • 资助金额:
    $ 100.05万
  • 项目类别:
A behavioral intervention for Black men who have sex with men and live with HIV to address intersectional stigma and improve antiretroviral therapy adherence
针对男男性行为且感染艾滋病毒的黑人男性进行行为干预,以解决交叉耻辱并提高抗逆转录病毒治疗的依从性
  • 批准号:
    10432133
  • 财政年份:
    2021
  • 资助金额:
    $ 100.05万
  • 项目类别:
A behavioral intervention for Black men who have sex with men and live with HIV to address intersectional stigma and improve antiretroviral therapy adherence
针对男男性行为且感染艾滋病毒的黑人男性进行行为干预,以解决交叉耻辱并提高抗逆转录病毒治疗的依从性
  • 批准号:
    10327065
  • 财政年份:
    2021
  • 资助金额:
    $ 100.05万
  • 项目类别:
Leveraging Technology to Address Access and Adherence to Conventional Hospital-Based Pulmonary Rehabilitation in Veterans with COPD
利用技术解决慢性阻塞性肺病退伍军人接受和坚持传统医院肺康复的问题
  • 批准号:
    10377366
  • 财政年份:
    2019
  • 资助金额:
    $ 100.05万
  • 项目类别:
Leveraging Technology to Address Access and Adherence to Conventional Hospital-Based Pulmonary Rehabilitation in Veterans with COPD
利用技术解决慢性阻塞性肺病退伍军人接受和坚持传统医院肺康复的问题
  • 批准号:
    10574496
  • 财政年份:
    2019
  • 资助金额:
    $ 100.05万
  • 项目类别:
Targeted interventions to address the multi-level effects of gender-based violence on PrEP uptake and adherence among adolescent girls and young women in Kenya
有针对性的干预措施,以解决性别暴力对肯尼亚少女和年轻妇女接受和坚持 PrEP 的多层面影响
  • 批准号:
    9403567
  • 财政年份:
    2017
  • 资助金额:
    $ 100.05万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了